Tag: immunoglobulins market analysis

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

At What Rate is the Immunoglobulins Market Predicted to Expand Between 2024 and 2033?

The immunoglobulins market has seen strong growth in recent years. It will increase from $17.49 billion in 2023 to $19.07 billion in 2024, growing at a CAGR of 9.1%. The growth is attributed to the rising prevalence of immunodeficiency disorders, the aging population, the growing use of immunoglobulins in hospitals, favorable government reimbursement plans, and the increasing prevalence of chronic and autoimmune diseases.

The immunoglobulins market size is projected to reach $28.3 billion in 2028, growing at a CAGR of 10.4%. The growth is driven by increasing investment in advanced technologies, the rising demand for immunodeficiency therapies, and the expansion of applications in sports and fitness. Trends include the development of wearable devices and the customization of compression therapy solutions.

Claim Your Free Sample of the Global Immunoglobulins Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=5284&type=smp

What Forces Are Boosting the immunoglobulins Market’s Growth?

The immunoglobulins market is growing, propelled by the increasing geriatric population. Elderly individuals, prone to infectious and autoimmune diseases, drive demand for immunoglobulin tests to assess antibody production. The World Health Organization projects one in six people globally to be aged 60 or older by 2030, reaching 2.1 billion individuals by 2050. The expanding geriatric demographic contributes significantly to the heightened demand for immunoglobulins in the market.

What Key Segments Make Up the Immunoglobulins Market?

1) By Product: IGG, IGA, IGM, IGE, IGD.

2) By Mode Of Delivery: Intravenous Mode of Delivery, Subcutaneous Mode of Delivery

3) By Application: Hypogammaglobulinemia, Chronic Inflammatory demyelinating polyneuropathy (CIDP), Immunodeficiency Disease, Myasthenia Gravis, Idiopathic thrombocytopenic purpura (ITP), Other Applications

What Are the Latest Trends Impacting the 58 Market?

The immunoglobulins market is witnessing the establishment of new offices and laboratories to drive research and development activities. Major companies in this sector are opening new facilities to bolster platform technology, pipeline development, and manufacturing capabilities. For instance, in February 2021, VectorY, a gene therapy firm, inaugurated offices and laboratories in the Netherlands to develop novel vectorized antibodies for muscular and neurological diseases. These facilities enable VectorY to undertake exclusive and collaborative projects leveraging revolutionary AAV platform and antibody-based targeted degradation technology to address the limitations of current therapies.

Order Now for Fast Delivery of Your Immunoglobulins Market Report!

https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

What Regions Are Dominating the Immunoglobulins Market Growth?

North America was the largest region in the immunoglobulins market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunoglobulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Immunoglobulins Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the immunoglobulins market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Immunoglobulins Market Include

1. Immunoglobulins Market Executive Summary

2. Immunoglobulins Market Segments

3. Immunoglobulins Market Size And Template Market Growth Rate

4. Key Immunoglobulins Market Trends

5. Major Immunoglobulins Market Drivers

……

25. Key Mergers And Acquisitions In The Immunoglobulins Market

26. Top Immunoglobulins Companies

27. Immunoglobulins Market Opportunities And Strategies

28. Immunoglobulins Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

IoT Connectivity Management Platform Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/iot-connectivity-management-platform-global-market-report

Computed Tomography (CT) Scanners Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/computed-tomography-ct-scanners-devices-and-equipment-global-market-report

Autonomous Aircraft Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/autonomous-aircraft-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Immunoglobulins Global Market Report 2024, the immunoglobulins market is expected to show promising growth in the forecast period.

The immunoglobulins market has experienced robust growth in recent years, with the market size surging from $17.49 billion in 2023 to a projected $19.07 billion in 2024, marking an impressive compound annual growth rate (CAGR) of 9.1%. This upward trend is attributed to factors such as the increased prevalence of immunodeficiency disorders, a growing geriatric population, rising adoption of immunoglobulins in hospitals, favorable government reimbursement plans, and the escalating prevalence of chronic and autoimmune diseases.

Factors Driving Growth in the Historic Period

• Increased prevalence of immunodeficiency disorders
• Growing geriatric population
• Rising adoption of immunoglobulins in hospitals
• Favorable government reimbursement plans
• Increasing prevalence of chronic and autoimmune diseases

Factors Propelling Growth in the Forecast Period

• Increasing investment for advanced technologies
• Growing awareness about immunodeficiency therapies
• Rising preference among physicians for immunodeficiency therapies
• Increasing number of emerging markets
• Expansion of applications in sports and fitness

Major Trends in the Forecast Period

• Development of wearable and smart compression devices
• Customization of compression therapy solutions
• Integration of compression therapy in wound care management
• Emphasis on patient comfort and compliance in compression therapy
• Collaboration between manufacturers and healthcare providers for improved patient outcomes

Healthcare Expenditures as Growth Catalyst

The immunoglobulins market is poised for further growth, driven by the anticipated increase in healthcare expenditures. Healthcare expenditure, encompassing spending on services, treatments, medications, and medical equipment, plays a pivotal role in driving research and development in the immunoglobulins sector. As an example, the Centers for Medicare & Medicaid Services in the US projected an average annual rise of 5.1% in national health spending, reaching nearly $6.8 trillion between 2021 and 2030. This surge in funding is expected to contribute significantly to the advancement of immunoglobulins therapies.

Industry Leaders Shaping the Landscape

Several major companies play a crucial role in shaping the immunoglobulins market:

• Baxter International Inc.
• CSL Behring LLC
• Grifols S. A.
• Octapharma AG
• And many more…

View More On The Immunoglobulins Market Report 2024 – https://www.thebusinessresearchcompany.com/report/immunoglobulins-global-market-report

Driving Innovation in the Market

Innovation stands at the forefront of the immunoglobulins market, with major companies developing groundbreaking products to meet expanding customer bases, drive sales, and increase revenue. One notable example is Pfizer Inc.’s PANZYGA, an intravenous immunoglobulin (IVIG) approved by the U.S. Food and Drug Administration in February 2021. PANZYGA offers two FDA-approved maintenance dosing alternatives for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), showcasing a commitment to addressing diverse clinical requirements.

Strategic Acquisitions for Market Expansion

In a strategic move in October 2022, AbbVie Inc., a leading pharmaceutical company, acquired DJS Antibodies Ltd. This acquisition is poised to enhance AbbVie’s antibody research capabilities, fortify its immunology portfolio, and establish a robust presence in the bioscience hub in Oxford, UK. The acquisition provides AbbVie access to the HEPTAD platform, complementing its biotherapeutics research capabilities. Simultaneously, DJS Antibodies Ltd. aims to leverage AbbVie’s drug discovery expertise to continue developing antibody therapeutics and explore novel biological insights.

Comprehensive Market Segmentation

The immunoglobulins market is intricately segmented to provide a nuanced understanding of its dynamics:

1. By Product:
   • IGG
   • IGA
   • IGM
   • IGE
   • IGD
2. By Mode Of Delivery:
   • Intravenous Mode of Delivery
   • Subcutaneous Mode of Delivery
3. By Application:
   • Hypogammaglobulinemia
   • Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
   • Immunodeficiency Disease
   • Myasthenia Gravis
   • Idiopathic Thrombocytopenic Purpura (ITP)
   • Other Applications

Regional Dynamics

North America emerged as the largest region in the immunoglobulins market in 2023, with Asia-Pacific expected to be the fastest-growing region in the forecast period. This geographical shift underscores the global nature of the market, reflecting widespread adoption and application of immunoglobulin therapies.

In conclusion, the immunoglobulins market is on an upward trajectory, driven by factors like increased healthcare expenditures, innovative product developments, and strategic acquisitions. With major players at the forefront of advancements, the market is poised for rapid expansion, ushering in a new era of immunodeficiency therapies and healthcare solutions.

Request A Sample Of The Global Immunoglobulins Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=5284&type=smp